Funding Rounds
Precirix

Precirix Series A (2018, $40M)

Precirix

Manufacturer of radio-immunotherapeutic drugs for cancer patients.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $40.00M

Investors